EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2
Faten Bougatef, Suzanne Menashi, Farah Khayati et al. · 2010
Read EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2 by Faten Bougatef, Suzanne Menashi, Farah Khayati et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012265.txt.
Description
Faten Bougatef, Suzanne Menashi, Farah Khayati, and co-authors studied a surface protein that worsens melanoma, in PLOS ONE in 2010. The protein, EMMPRIN, shows up in melanoma tissue where patients fare poorly, but the route from its presence to a worse cancer needed proof. Working with two melanoma cell lines grown from patients' tumors, the team traced what EMMPRIN switches on.
They show it raises a growth-factor receptor on the cancer cells, through a low-oxygen response protein, and that this makes the cells migrate and multiply more. Each named link is a place a drug might cut in. For melanoma, which resists most treatments once spread, a chain of targets beats a single hope.
Catalog record
| CREATOR | Faten Bougatef, Suzanne Menashi, Farah Khayati et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012265